Valuation: Boryung Corporation

Market Cap 714B 466M 408M 375M 349M 662M 44.41B 672M 4.5B 1.75B 21.83B 1.75B 1.71B 75.22B P/E 2026 *
10.9x
P/E 2027 * 10.6x
Enterprise Value 714B 466M 408M 375M 349M 662M 44.41B 672M 4.5B 1.75B 21.83B 1.75B 1.71B 75.22B EV / Sales 2026 *
0.67x
EV / Sales 2027 * 0.66x
Free-Float
32.71%
Yield 2026 *
1.89%
Yield 2027 * 1.89%
1 day+1.44%
1 week+4.06%
Current month+0.48%
1 month-1.86%
3 months-7.45%
6 months-9.63%
Current year-6.22%
1 week 8,130
Extreme 8130
8,680
1 month 7,910
Extreme 7910
9,730
Current year 7,910
Extreme 7910
10,800
1 year 7,910
Extreme 7910
10,800
3 years 7,440
Extreme 7440
13,750
5 years 7,440
Extreme 7440
20,200
10 years 5,743.71
Extreme 5743.7069
25,083.33
Manager TitleAgeSince
Chief Executive Officer 41 25/03/2022
Director of Finance/CFO 51 -
Chief Tech/Sci/R&D Officer 55 -
Director TitleAgeSince
Director/Board Member 94 -
Chairman 68 19/05/2014
Director/Board Member 60 25/03/2022
Date Insider Type Main position Quantity % Market Cap.
12/06/25Buy 117,572 0.1355%
12/06/25Buy

Director

400,000 0.4609%
22/05/25Buy

Responsable ventes & marketing

1,000 0.0012%
Change 5-day change 1-year change 3-year change Capi.($)
+1.44%+4.06%-0.59%+2.80% 466M
+1.81%+2.25%+13.40%+84.45% 48B
-2.54%+3.72%+65.71%+113.61% 36.89B
+0.15%+1.26%-3.35%+45.56% 12.37B
+3.71%+3.56%+14.13%+97.20% 11.95B
+0.39%+0.58%+33.25%+119.07% 9.01B
+0.66%-0.57%+19.28%+45.55% 7.2B
+0.71%+1.75%+53.59%-7.09% 7.05B
+0.68%+2.63%+23.97%+235.28% 6.55B
+9.99%+32.94%-15.69%+27.08% 6.58B
Average +1.70%+3.63%+20.37%+76.35% 14.61B
Weighted average by Cap. +0.85%+3.34%+27.83%+89.29%

Financials

2026 *2027 *
Net sales 1,058B 691M 604M 555M 517M 982M 65.8B 996M 6.67B 2.59B 32.34B 2.59B 2.54B 111B 1,084B 708M 619M 569M 530M 1.01B 67.44B 1.02B 6.83B 2.66B 33.15B 2.66B 2.6B 114B
Net income 66.2B 43.25M 37.81M 34.75M 32.39M 61.43M 4.12B 62.36M 417M 162M 2.02B 162M 159M 6.98B 68.2B 44.56M 38.95M 35.8M 33.37M 63.29M 4.24B 64.25M 430M 167M 2.09B 167M 164M 7.19B
Net Debt - -
Logo Boryung Corporation
Boryung Corp, formerly Boryung Pharm Co Ltd, is a Korea-based company principally engaged in the manufacture and sale of pharmaceutical products. The Company mainly manufactures and distributes pharmaceutical products including antihypertensive drugs, gastrointestinal disorder drugs, antibiotics, gastric ulcer drugs, oral antibiotics, anticancer drugs and antihyperlipidemic drugs, among others. The Company distributes its products in domestic and overseas markets.
Employees
1,533
Date Price Change Volume
03/07/26 ₩8,450.00 +1.44% 131,288
02/07/26 ₩8,330.00 -1.88% 104,838
01/07/26 ₩8,490.00 +0.95% 88,489
30/06/26 ₩8,410.00 -2.32% 95,256
29/06/26 ₩8,610.00 +6.03% 125,526
Trader
-
Investor
Global
-
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
8,450.00KRW
Average target price
14,000.00KRW
Spread / Average Target
+65.68%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A003850 Stock